Stada expands its European treatment portfolio
Company adds a number of additional brands from Sanofi following initial take overs in 2021
Read More
Tag: Stada
Stada and Xbrane receive approval for Ximluci
Biosimilar gains MHRA marketing authorisation for use throughout Britain
Read More
Stada and Xbrane gain EU approval for biosimilar Ximluci
Partnership combines Xbrane’s protein-expression system with Stada’s management teams
Read More
Stada launches prostate cancer treatment across 21 European countries
Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer
Read More
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
